Shares of Alamar Biosciences Inc. are expected to begin trading on the Nasdaq Global Select Market, under the ticker symbol "ALMR", on April 17, 2026.
This commercial-stage proteomics company has developed a proprietary NULISA technology to overcome the limitations of traditional proteomics tools, enabling the detection of protein biomarkers at extremely low concentrations using non-invasive biological samples such as blood.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.